{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:18:38Z","timestamp":1790410718961,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.cgh.2007.02.004","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T07:17:49Z","timestamp":1174979869000},"page":"451-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Treatment of Travelers\u2019 Diarrhea: Randomized Trial Comparing Rifaximin, Rifaximin Plus Loperamide, and Loperamide Alone"],"prefix":"10.1016","volume":"5","author":[{"given":"Herbert L.","family":"Dupont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi\u2013Dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Belkind\u2013Gerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo C.","family":"Okhuysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Ericsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret W.","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier A.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Javier","family":"De La Cabada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridvya","family":"Jaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Martinez Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2007.02.004_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11938-006-0020-9","article-title":"Travelers\u2019 diarrhea: modern concepts and new developments","volume":"9","author":"DuPont","year":"2006","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.cgh.2007.02.004_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(00)02451-X","article-title":"Risk and aetiology of diarrhoea at various tourist destinations","volume":"356","author":"von Sonnenburg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2007.02.004_bib3","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1056\/NEJM197606102942401","article-title":"Travelers\u2019 diarrhea in Mexico","volume":"294","author":"Merson","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib4","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jama.1983.03330330054035","article-title":"Epidemiology of diarrhea in travelers","volume":"249","author":"Steffen","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2007.02.004_bib5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJM197505012921801","article-title":"Travelers\u2019 diarrhea and toxigenic Escherichia coli","volume":"292","author":"Gorbach","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib6","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJM199306243282507","article-title":"Prevention and treatment of traveler\u2019s diarrhea","volume":"328","author":"DuPont","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/338834","article-title":"Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)","volume":"185","author":"Jiang","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cgh.2007.02.004_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/21.2.341","article-title":"Zaldaride maleate (a new calmodulin antagonist) versus loperamide in the treatment of travelers\u2019 diarrhea: randomized, placebo-controlled trial","volume":"21","author":"Okhuysen","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2007.02.004_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jama.1986.03370060071021","article-title":"Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers\u2019 diarrhea","volume":"255","author":"Johnson","year":"1986","journal-title":"JAMA"},{"issue":"Suppl 6A","key":"10.1016\/j.cgh.2007.02.004_bib10","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1016\/0002-9343(90)90270-N","article-title":"Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea","volume":"88","author":"DuPont","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jama.1990.03440020091039","article-title":"Treatment of traveler\u2019s diarrhea with sulfamethoxazole and trimethoprim and loperamide","volume":"263","author":"Ericsson","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2007.02.004_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.45.1.212-216.2001","article-title":"In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler\u2019s diarrhea in four geographic regions","volume":"45","author":"Gomi","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cgh.2007.02.004_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1159\/000007580","article-title":"Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers\u2019 diarrhea","volume":"59","author":"DuPont","year":"1998","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2007.02.004_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1572-0241.2003.07283.x","article-title":"Therapy of travelers\u2019 diarrhea with rifaximin on various continents","volume":"98","author":"Steffen","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2007.02.004_bib15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2006.74.1060","article-title":"A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers\u2019 diarrhea","volume":"74","author":"Taylor","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cgh.2007.02.004_bib16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1086\/323814","article-title":"Rifaximin versus ciprofloxacin for the treatment of traveler\u2019s diarrhea: a randomized, double-blind clinical trial","volume":"33","author":"DuPont","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2007.02.004_bib17","series-title":"Azithromycin and loperamide is comparable to levofloxacin and loperamide for the treatment of traveler\u2019s diarrhea in US military personnel in Turkey","author":"Sanders","year":"2005"},{"key":"10.1016\/j.cgh.2007.02.004_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.7326\/0003-4819-114-9-731","article-title":"Treatment of travelers\u2019 diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone","volume":"114","author":"Taylor","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/165.3.557","article-title":"Treatment of traveler\u2019s diarrhea with ciprofloxacin and loperamide","volume":"165","author":"Petruccelli","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cgh.2007.02.004_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1708-8305.1997.tb00765.x","article-title":"Single dose ofloxacin plus loperamide compared with single dose or three days of ofloxacin in the treatment of traveler\u2019s diarrhea","volume":"4","author":"Ericsson","year":"1997","journal-title":"J Travel Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00006454-198709000-00008","article-title":"Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells","volume":"6","author":"Nataro","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cgh.2007.02.004_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/jcm.28.5.882-885.1990","article-title":"Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea","volume":"28","author":"Vial","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cgh.2007.02.004_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2307\/2530299","article-title":"Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint","volume":"38","author":"Schoenfeld","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.cgh.2007.02.004_bib24","series-title":"Program of the 9th Conference of the International Society of Travel Medicine","article-title":"Azithromycin (500 mg) plus loperamide effectively treats travelers\u2019 diarrhea in Mexico","author":"Ericsson","year":"2005"},{"key":"10.1016\/j.cgh.2007.02.004_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/AAC.36.1.87","article-title":"Five versus three days of ofloxacin therapy for traveler\u2019s diarrhea: a placebo-controlled study","volume":"36","author":"DuPont","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cgh.2007.02.004_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM198209303071401","article-title":"Treatment of travelers\u2019 diarrhea with trimethoprim\/sulfamethoxazole and with trimethoprim alone","volume":"307","author":"DuPont","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib27","series-title":"Rifaximin alteration of microbial virulence of enterotoxigenic Escherichia coli","author":"Jiang","year":"2005"},{"key":"10.1016\/j.cgh.2007.02.004_bib28","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/jcm.26.5.1047-1049.1988","article-title":"Test-of-cure stool cultures for traveler\u2019s diarrhea","volume":"26","author":"Ericsson","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cgh.2007.02.004_bib29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-142-10-200505170-00005","article-title":"A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers\u2019 diarrhea","volume":"142","author":"DuPont","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1469-0691.2004.00997.x","article-title":"Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci","volume":"10","author":"DuPont","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2007.02.004_bib31","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib32","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile","volume":"353","author":"McDonald","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.02.004_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000007297","article-title":"In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species","volume":"46","author":"Marchese","year":"2000","journal-title":"Chemotherapy"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507001723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507001723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:59:29Z","timestamp":1761541169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356507001723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1542356507001723"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2007.02.004","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Travelers\u2019 Diarrhea: Randomized Trial Comparing Rifaximin, Rifaximin Plus Loperamide, and Loperamide Alone","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2007.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}